Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 30, 2017

View Archived Issues

Hair follicle stem cell metabolism can be exploited to activate the hair cycle

AstraZeneca and Takeda partner to develop and commercialize MEDI-1341 for Parkinson's disease

Boston Pharmaceuticals licenses Daiichi's DS-5010

Seattle Genetics exercises option to codevelop tisotumab vedotin with Genmab

Moleculin files IND to study annamycin for relapsed or refractory AML

Combination of TRC-105 plus sorafenib demonstrates promising safety and efficacy in HCC

Acorda receives refusal to file letter from FDA regarding Inbrija NDA

FDA grants rare pediatric disease designation to Prometic's Ryplazim

FDA grants fast track designation for MitoGel for the treatment of upper tract urothelial carcinoma

Celgene exercises option to extend collaboration with Forma

Jazz Pharmaceuticals and ImmunoGen enter strategic collaboration and option agreement

Mydayis now available in U.S.

Bristol-Myers Squibb selectively targets TYK2 for autoimmune, inflammatory diseases

Anthera reports topline data from BRIGHT-SC extension of blisibimod in IgA nephropathy

GlobeImmune announces clinical program updates

Selective 5-HT2B receptor antagonists derived at AnaMar AB to treat fibrosis

Mologen signs binding term sheet for lefitolimod collaboration with iPharma

miR-92a identified as a potential biomarker of rapid aortic valve calcification

Redx Pharma identifies compounds for treating mycobacterial infections

FDA grants breakthrough therapy designation to EB-101 for recessive dystrophic epidermolysis bullosa

FDA grants breakthrough therapy designation to DS-8201 for HER2-positive metastatic breast cancer

European Molecular Biology Laboratory, Savira Pharmaceuticals divulge compounds for influenza

Mazor Robotics and Medtronic enter next phase of strategic partnership

Thermo Fisher Scientific announces completion of its acquisition of Patheon

Immix closes Series A financing to support lead candidate Imx-110

FDA accepts for priority review BioMarin's BLA for pegvaliase for PKU

Apricus resubmits Vitaros NDA

FDA grants accelerated approval to benznidazole for children with Chagas disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...